Periodically, ExSAR’s therapies for Lysosomal Storage Disorders and Protein Misfolding will enter the clinical trial phase. Below is the status of current clinical trials. This list is updated with new clinical trials so check back often.

Phase I Study of EXR-101 (pyrimethamine) in Patients With Late-Onset (Adult) Tay-Sachs

This study has been temporarily suspended.

Lysosomal Storage Disorders and Protein Misfolding | Product Pipeline | Clinical Trials